| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d020a48d98509e59fb4df2fa879371c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a933a0dd561e3e50b278738704d5c6e6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2510-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-475 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19 |
| filingDate |
2008-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1f7049fde68f5ea3739dfd273eb28b1 |
| publicationDate |
2009-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009036149-A2 |
| titleOfInvention |
Methods for treatment of degenerative disease associated with apoptosis |
| abstract |
A method for treating a degenerative disease or neurodegenerative disease in a mammalian subject is provided. The method provides administering VEGF-B polypeptide or functional variant or mimetic thereof in an amount effective to reduce or eliminate the degenerative disease in the mammalian subject without having any substantial angiogenic effect across all dosage levels. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107106681-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016527301-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-MI20131351-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2529745-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9963514-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2744909-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107106681-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021140173-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2014304208-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012163542-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015019230-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10336821-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10961304-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9415090-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016077878-A1 |
| priorityDate |
2007-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |